SUN Pharmaceutical Industries
As of the edition of 20 October 2026, SUN Pharmaceutical Industries runs 53 drugs, 42 of them marketed; it is on route A at 0 targets and on route B at 1 target.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
The records place 3 company names in this family.
- Checkpoint Therapeutics, Inc.: acquired in 2025; successor SUN PHARMACEUTICAL INDUSTRIES INC
Drugs by status
| Status | Count |
|---|---|
| Marketed | 42 |
| Active | 1 |
| Went quiet | 6 |
| Stopped | 3 |
| Status not established | 1 |
| Total | 53 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Gemcitabine | none listed | 1 |
| Docetaxel anhydrous | none listed | 0 |
| Metformin | none listed | 4 |
| Cyclosporine | none listed | 3 |
| Rosuvastatin | none listed | 3 |
| Decitabine | none listed | 4 |
| Ruxolitinib | Ends 2029 (exclusivity) | 4 |
| Budesonide | Ends 2029 (exclusivity) | 5 |
| Leuprolide | Ended 2026 (exclusivity) | 1 |
| Duloxetine | none listed | 2 |
| Hydrocortisone | none listed | 5 |
| Abiraterone acetate | Ends 2038 (patent) | 0 |
| Triamcinolone acetonide | none listed | 3 |
| Furosemide | none listed | 2 |
| Octreotide | none listed | 5 |
| Metoprolol | none listed | 0 |
| Isotretinoin | none listed | 3 |
| Aminolevulinic acid | none listed | 0 |
| Teriparatide | none listed | 3 |
| Abiraterone | none listed | 3 |
| Latanoprost | none listed | 5 |
| Desvenlafaxine | Ends 2027 (patent) | 0 |
| Ranolazine | none listed | 4 |
| Sonidegib | Ends 2036 (patent) | 0 |
| Bromfenac | none listed | 2 |
A route B row is one company at one target. 17 more marketed drugs are not listed here.
Where it needs a new molecule
Route A at 0 targets, route B at 1 target.
| Target | Route |
|---|---|
| CD274 Programmed cell death 1 ligand 1 | Route B |
All 1 row on route A or B
In the product1 company-target row on route A or B; 0 are not shown here, and no score is.
See all 1 targets where SUN Pharmaceutical Industries needs a new molecule, with the facts behind eachRequest access. Nothing is shown until you do.
Where its trials are
- Eye: 5 trials led
- Cancer: 3 trials led
- Hormones: 3 trials led